Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

被引:112
作者
Ostler, K. R.
Davis, E. M.
Payne, S. L.
Gosalia, B. B.
Exposito-Cespedes, J.
Le Beau, M. M.
Godley, L. A.
机构
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
DNA methylation; DNMT3B; aberrant mRNA splicing; epigenetics;
D O I
10.1038/sj.onc.1210351
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells display an altered distribution of DNA methylation relative to normal cells. Certain tumor suppressor gene promoters are hypermethylated and transcriptionally inactivated, whereas repetitive DNA is hypomethylated and transcriptionally active. Little is understood about how the abnormal DNA methylation patterns of cancer cells are established and maintained. Here, we identify over 20 DNMT3B transcripts from many cancer cell lines and primary acute leukemia cells that contain aberrant splicing at the 50 end of the gene, encoding truncated proteins lacking the C-terminal catalytic domain. Many of these aberrant transcripts retain intron sequences. Although the aberrant transcripts represent a minority of the DNMT3B transcripts present, Western blot analysis demonstrates truncated DNMT3B isoforms in the nuclear protein extracts of cancer cells. To test if expression of a truncated DNMT3B protein could alter the DNA methylation patterns within cells, we expressed DNMT3B7, the most frequently expressed aberrant transcript, in 293 cells. DNMT3B7-expressing 293 cells have altered gene expression as identified by microarray analysis. Some of these changes in gene expression correlate with altered DNA methylation of corresponding CpG islands. These results suggest that truncated DNMT3B proteins could play a role in the abnormal distribution of DNA methylation found in cancer cells.
引用
收藏
页码:5553 / 5563
页数:11
相关论文
共 52 条
  • [1] Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients
    Aggerholm, A
    Holm, MS
    Guldberg, P
    Olesen, LH
    Hokland, P
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (01) : 23 - 32
  • [2] Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
    Bachman, KE
    Park, BH
    Rhee, I
    Rajagopalan, H
    Herman, JG
    Baylin, SB
    Kinzler, KW
    Vogelstein, B
    [J]. CANCER CELL, 2003, 3 (01) : 89 - 95
  • [3] Alternative and aberrant splicing of MDM2 mRNA in human cancer
    Bartel, F
    Taubert, H
    Harris, LC
    [J]. CANCER CELL, 2002, 2 (01) : 9 - 15
  • [4] An essential role for DNA methyltransferase DNMT3B in cancer cell survival
    Beaulieu, N
    Morin, S
    Chute, IC
    Robert, MF
    Nguyen, H
    MacLeod, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 28176 - 28181
  • [5] The DNA methyltransferases of mammals
    Bestor, TH
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (16) : 2395 - 2402
  • [6] E-cadherin in gastric cancer
    Chan, Annie On On
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (02) : 199 - 203
  • [7] Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
    Charlet-B, N
    Savkur, RS
    Singh, G
    Philips, AV
    Grice, EA
    Cooper, TA
    [J]. MOLECULAR CELL, 2002, 10 (01) : 45 - 53
  • [8] CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
  • [9] Cadherins and catenins in breast cancer
    Cowin, P
    Rowlands, TM
    Hatsell, SJ
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (05) : 499 - 508
  • [10] RNA surveillance - unforeseen consequences for gene expression, inherited genetic disorders and cancer
    Culbertson, MR
    [J]. TRENDS IN GENETICS, 1999, 15 (02) : 74 - 80